Samuel Silva graduated in Biomedical Sciences at the University Institute of Health Sciences (IUCS, Gandra, Portugal) in 2017. In 2020 he completed an MSc in Analytical, Clinical and Forensic Toxicology at the Faculty of Pharmacy of the University of Porto (FFUP, Portugal). His master's thesis work was done in collaboration with the Abel Salazar Institute of Biomedical Sciences (ICBAS, University of Porto) studying the expression of P-glycoprotein in human Sertoli cells (blood-testis barrier). In 2021, he joined BITE (VUB, Belgium) as a PhD student and works in establishing human testicular organoids.